The total value of deals rose from $11.63 billion in 2012 to $11.81 billion in 2013. More than one-third of this value was found in a single transaction, BC Partners’ acquisition of Springer Science & Business Media for $4.42 billion.
Adding to the increase in deal value was an increase in valuations of health IT companies. The median revenue multiple increased from 2.3x to 2.5x, while the median EBITDA multiple improved from 9.9x to 10.7x.
Transaction values are expected to increase as health IT products are becoming “increasingly necessary to achieve operating efficiencies when dealing with a $3 trillion complex, rapidly evolving landscape with respect to regulatory requirements (ICD-10, meaningful use stage 2), new payment and delivery models and declining reimbursement rates,” said Jonathan Krieger, Managing Director at Berkery Noyes, in a news release. “Private, middle-market, tech-enabled companies are at the forefront of developing these emerging, niche technologies and are in high demand by strategic and financial acquirers.”
More Articles on the Health IT Market:
5 Things to Know About This Week’s Connectathon
Philips Healthcare Launches IT Division
U.S., U.K. to Collaborate on Health IT Best Practices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
